Paper41007755
Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo.
Bharaj IS and 12 others. Biomedicines, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo. Papers, record 41007755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007755
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39030739 | Potential kidney protective effects of glucagon-like peptide-1 receptor agonists. | Nephrology (Carlton) | 2024 | https://conductscience.org/library/papers/39030739 | PubMed |
| 2 | 34329774 | Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34329774 | PubMed |
| 3 | 33107592 | Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/33107592 | PubMed |
| 4 | 38806171 | 2024 update in heart failure. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/38806171 | PubMed |
| 5 | 37793348 | Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis. | Am J Nephrol | 2024 | https://conductscience.org/library/papers/37793348 | PubMed |
| 6 | 36273831 | AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. | Gastroenterology | 2022 | https://conductscience.org/library/papers/36273831 | PubMed |
| 7 | 39225278 | Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39225278 | PubMed |
| 8 | 35713973 | Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. | Eur Heart J | 2022 | https://conductscience.org/library/papers/35713973 | PubMed |
| 9 | 37364790 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | J Hepatol | 2023 | https://conductscience.org/library/papers/37364790 | PubMed |
| 10 | 38301917 | Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies. | Curr Probl Cardiol | 2024 | https://conductscience.org/library/papers/38301917 | PubMed |
| 11 | 40316962 | CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40316962 | PubMed |
| 12 | 34581310 | ANGPTL3 as therapeutic target. | Curr Opin Lipidol | 2021 | https://conductscience.org/library/papers/34581310 | PubMed |
| 13 | 35419980 | Association of lipoprotein (a) and 1 year prognosis in patients with heart failure with reduced ejection fraction. | ESC Heart Fail | 2022 | https://conductscience.org/library/papers/35419980 | PubMed |
| 14 | 35363499 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2022 | https://conductscience.org/library/papers/35363499 | PubMed |
| 15 | 40383455 | The role of finerenone in heart failure. | Trends Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40383455 | PubMed |
| 16 | 40575425 | Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. | World J Cardiol | 2025 | https://conductscience.org/library/papers/40575425 | PubMed |
| 17 | 35624390 | Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management. | Curr Atheroscler Rep | 2022 | https://conductscience.org/library/papers/35624390 | PubMed |
| 18 | 38860394 | Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38860394 | PubMed |
| 19 | 38718937 | A review regarding the article 'Electrocardiographic abnormalities in patients with metabolic dysfunction-associated Steatotic liver disease: A systematic review and meta-analysis.' | Curr Probl Cardiol | 2024 | https://conductscience.org/library/papers/38718937 | PubMed |
| 20 | 32981345 | Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association. | Circulation | 2020 | https://conductscience.org/library/papers/32981345 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42859730 | Exerkines in Cardiovascular-Kidney-Metabolic Syndrome: An Integrative Framework for Mechanisms and Therapeutic Implications-A Narrative Review. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42859730 | PubMed |
| 42837317 | A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study. | PLoS Med | 2026 | https://conductscience.org/library/papers/42837317 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| LPA | 4018 | PubTator's text mining | https://conductscience.org/library/genes/4018 | NCBI Gene |
| PCSK9 | 255738 | PubTator's text mining | https://conductscience.org/library/genes/255738 | NCBI Gene |
| SLC5A2 | 6524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
| THRB | 7068 | PubTator's text mining | https://conductscience.org/library/genes/7068 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007755
GET https://conductscience.org/api/papers/v1/41007755/references?page=2